Order Article Reprints

Battelli N, Mocerino C, Montedoro M, Pistelli M, Portarena I, Rosanova M, Sidoni T, Vici P. New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2−Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III. Current Oncology. 2025; 32(4):192. https://doi.org/10.3390/curroncol32040192

Battelli, Nicola, Carmela Mocerino, Michele Montedoro, Mirco Pistelli, Ilaria Portarena, Mario Rosanova, Tina Sidoni, and Patrizia Vici. 2025. "New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2−Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III" Current Oncology 32, no. 4: 192. https://doi.org/10.3390/curroncol32040192

Battelli, N., Mocerino, C., Montedoro, M., Pistelli, M., Portarena, I., Rosanova, M., Sidoni, T., & Vici, P. (2025). New Therapeutic Scenarios in the Context of Adjuvant Treatment for HR+/HER2−Breast Cancer: The Possible Role of Ribociclib in Treatment Algorithms for Stage II and III. Current Oncology, 32(4), 192. https://doi.org/10.3390/curroncol32040192